Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.
← catalyst calendarSponsored by Colgate Palmolive (industry) · CL — their whole pipeline →.
Phase
Phase 3
Status
Completed
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
134actual
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-01-26 | actual | When the study began enrolling |
| Primary completion | 2026-04-29 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-04-29 | actual | The whole study's end, after follow-up |
| First posted | 2026-02-10 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-22 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Plaque
Interventions
- Drug: 0.454%Stannous fluoride toothpaste
- Drug: 0.075% Cetylpyridinium Chloride (CPC) and 0.28% zinc lactatmouthwashe
- Drug: 0.76% Sodium Monofluorophosphate (Na MFP) toothpaste
- Drug: 0.022% Sodium Fluoride mouthwash
Primary outcomes
what the primary-completion date above is the date OFLoe-Silness Gingival Index
measured Baseline, 6-weeks, and 12-weeks
Rustogi Modification of the Navy Plaque Index
measured Baseline, 6-weeks, and 12-weeks
Permalink · CL's whole pipeline · Catalyst calendar · Every registered study · What changed